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LETTERS TO THE EDITORRegarding “Increased 18F-fluorodeoxyglucose
uptake in abdominal aortic aneurysms in positron
emission/computed tomography is associated with
inflammation, aortic wall instability, and acute
symptoms”
The excellent study by Reeps et al demonstrated increased aor-
tic 18F-fluorodeoxyglucose (18F-FDG) metabolism measured by
positron emission tomography (PET) CT scans in patients with
asymptomatic abdominal aortic aneurysms (AAAs) compared with
healthy controls (mean maximum standard uptake values [SUVmax],
3.5 0.6 vs 3.0 0.5, respectively; P .05).1 Furthermore, patients
with symptomatic AAAs had significantly higher focal 18F-FDG
metabolism compared with those individuals with asymptomatic
AAAs (mean SUVmax, 7.5  0.3 vs 3.5  0.6, respectively; P 
.001).1 As the authors themselves concluded, these results suggest
that “18F-FDG PET CT imaging might be a new approach to
identify AAAs at risk before acute aneurysm onset”.1 These findings
support (and complete) the results of an earlier study.2
Based on international guidelines,3 the main criterion for
surgical treatment of AAAs is their size (5.5 cm); however, some
AAAs rupture when they are small.1,4 A marker for AAA wall
instability (such as 18F-FDG) could help identify patients at great-
est risk for AAA rupture.1,2 Besides this, however, it would be
interesting to determine whether 18F-FDG has the potential to act
as a predictor of AAA growth and instability. This could be
accomplished by recruiting patients with small (3.0-4.5 cm) AAAs
and having them undergo a baseline 18F-FDG PET CT scan.
These patients should then be followed-up by ultrasound to record
AAA expansion. By repeating the 18F-FDG PET CT scan after a
certain period of time (eg, 3 years), it may be possible to determine
if 18F-FDG uptake is associated with AAA expansion. Such an
association may hold implications for the earlier surgical manage-
ment of some AAA patients (and/or the conservative management
of others). In addition, such an association would help evaluate the
effect of conservative measures on AAAs (eg, with statins).5
Kosmas I. Paraskevas, MD, FASA
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Reply
In our manuscript “Increased 18F-fluorodeoxyglucose uptake
in abdominal aortic aneurysms in positron emission/computed
tomography is associated with inflammation, aortic wall instability,
and acute symptoms,” we demonstrated that fluorodeoxyglucose
(FDG)-uptake may be a marker of aortic wall instability in abdom-
inal aortic aneurysm (AAA) patients. In particular, assessment of
FDG-uptake may be useful to detect small aneurysms with high
risk for progression or rupture. To prove the real prognostic value
of positron emission/computed tomography (PET/CT) in this
context, a large prospective study with a well-defined patient
collective would be useful with the best statistical power as sug-
gested in the letter of K. I. Paraskevas. However, as commonly
known in AAA formation, periods of rapid progression are inter-
rupted by periods of stability. Consequently, the glucose metabo-
lism may not be continuously elevated, and each patient needs to
be scanned repeatedly, leading to excessive radiation exposure. In
patients with low risk of rupture, this additional and potentially
harmful radiation exposure seems unacceptable for ethical reasons.
In contrast, patients with higher risk of rupture need to undergo
early surgery. Therefore, a prospective study should focus on the
small group of patients deemed as unfit for AAA repair. Alterna-
tively, our study group tried to answer this question retrospec-
tively, and we initiated a retrospective study about the FDG-uptake
in cancer patients with concomitant AAA. Unfortunately, in this
patient collective, prevalence of AAA was under-represented re-
sulting in an undersized study cohort. Moreover in this study
group, the follow-up period was limited by the short survival rates
of these cancer patients. Therefore, a retrospective multicenter
study might be helpful to assess the prognostic value of increased
FDG up-take in small AAA without the potential harms of addi-
tional radiation exposure. Alternatively, the correlation of glucose
metabolism and wall stability may be studied in a realistic animal
model of AAA.
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